RespireRx Pharmaceuticals Inc (RSPI): News today on French site https://www...

Send PM Follow Ignore

Re: None

Wednesday, 03/20/2024 10:24:54 AM

Wednesday, March 20, 2024 10:24:54 AM

News today on French site

https://www.zonebourse.com/cours/action/RESPIRERX-PHARMACEUTICALS-111313448/actualite/RespireRx-Pharmaceuticals-Inc-annonce-la-publication-de-resultats-de-recherche-preclinique-demon-46242670/

RespireRx Pharmaceuticals Inc. annonce la publication de résultats de recherche préclinique démontrant la capacité du CX1739, sa principale AMPAkine clinique, à améliorer la fonction vésicale après une lésion de la moelle épinière.
Le 20 mars 2024 à 13:30

Keep Last Read

Next 10 Prev Next

Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2024 12:45:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 12:30:23 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/08/2024 08:01:32 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2024 01:03:20 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 01:30:27 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 01:45:38 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2023 01:45:18 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/17/2023 09:06:03 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 09:05:14 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/12/2023 01:00:21 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 12:45:26 PM